Title: An act relating to an early detection breast and cervical cancer screening program.

Brief Description: Establishing an early detection breast and cervical cancer screening program.

Sponsors: Senators Keiser, Deccio, Kastama, Parlette, Thibaudeau, McAuliffe, Brown, Rasmussen, Rockefeller and Kohl-Welles.

Brief History:

Health Care: 3/29/05, 3/31/05 [DPA].

HOUSE COMMITTEE ON HEALTH CARE

Majority Report: Do pass as amended. Signed by 13 members: Representatives Cody, Chair; Campbell, Vice Chair; Morrell, Vice Chair; Bailey, Ranking Minority Member; Curtis, Assistant Ranking Minority Member; Alexander, Appleton, Clibborn, Green, Hinkle, Lantz, Moeller and Schual-Berke.

Staff: Molly Belozer (786-7104).

Background:

In 1990, Congress passed the Breast and Cervical Cancer Mortality Prevention Act to provide
grants to states for the purpose of screening women for breast and cervical cancer. The Centers for Disease Control and Prevention (CDC) developed the National Breast and
Cervical Cancer Early Detection Program in 1991 to help low income, uninsured, and
underserved women gain access to screening programs for early detection of breast and
cervical cancer. Implemented in all 50 states, the program provides clinical breast
examinations, mammograms, pap tests, surgical consultation, and diagnostic testing for
women with abnormal screening results.

The Department of Health (Department), through a CDC grant, administers a breast and
cervical cancer early detection program for low-income women. Federal funding from FY00
to FY04 was $15 million, and the state is required to contribute $1 for every $3 of federal
funding. The Legislature has appropriated an annual $1 million for breast and cervical cancer
screening, coordination, and outreach services.

Breast cancer is the second most commonly diagnosed cancer among American women;
according to a report on cancer statistics from the CDC and the National Cancer Institute,
Washington has the highest incidence of breast cancer in the nation. According to the
Department, early detection screening could prevent approximately 15 to 30 percent of breast
cancer deaths among women over the age of 40.

Cervical cancer has a low incidence in the United States. According to the CDC, human
papillomavirus (HPV) infection is a strong risk factor for cervical cancer, but regular Pap
tests can detect HPV infection and pre-cancers. The Department believes that early detection
screening can prevent most cervical cancer deaths.

Summary of Amended Bill:

The Department must administer a state-supported early detection breast and cervical cancer
screening program to assist eligible women with preventive health services. The screening
program may enroll eligible women and, as funds are available, to expand the program to
additional eligible women. Eligible women are defined as women aged 40-64, with income
at or below 250 percent of the federal poverty level.

The funding from the state must not be used to replace federally-funded breast and cervical
cancer early detection programs, but will be used to operate Department-approved programs
or increase access to existing state-approved programs.

The Department must establish a Medical Advisory Committee (Committee) to provide
expert medical advice and guidance in addressing concerns and program policy
implementation of the early detection breast and cervical cancer screening program. The
Committee must include interested medical professionals and consumer liaisons with
expertise in areas relating to breast and cervical health.

Amended Bill Compared to Original Bill:

The amended bill specifies that eligible women may be enrolled, and additional women may be enrolled, to the extent of available funding. The amended bill contains a new section that details the continued enrollment in the program relating to funding. The amended bill also removes language about the program continuing only as long as the current federal funding level continues.

Appropriation: None.

Fiscal Note: Available.

Effective Date of Amended Bill: The bill takes effect 90 days after adjournment of session in which bill is passed.

Testimony For: The program is already in place due to federal funding, and has helped many women. It would be helpful for the program to have statutory framework, and would also give the program an elevated level of respect.

Testimony Against: None.

Persons Testifying: Patty Hayes, Department of Health; Susie Tracy, Susan G. Komen Breast Cancer Foundation; Julie Pietz; and Stacie Singleton.

Persons Signed In To Testify But Not Testifying: None.